Phibro Animal Health | PAHC - Nettoeinkommen

Aktienkurs
54.58
Täglich Wechseln
0.78 1.45%
Monatlich
2.79%
Jährlich
153.74%
Q1 Prognose
49.24




Nettoeinkommen Veränderung Datum
Align Technology USD 135.76M 79.01M 2025-12
ANI Pharmaceuticals USD 32.35M 6.08M 2025-12
Assertio Holdings USD -2.92M 753K 2024-09
Aurora Cannabis CAD 1.82M 53.29M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Canopy Growth CAD -62.63M 60.99M 2025-12
Corcept Therapeutics USD 24.29M 4.62M 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Henry Schein USD 101M 0 2025-12
Idexx Laboratories USD 248.19M 26.42M 2025-12
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Merck USD 2.96B 2.82B 2025-12
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Pacira USD 1.64M 3.8M 2025-12
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 46.7M 22.44M 2025-12
Supernus Pharmaceuticals USD -45.12M 67.62M 2025-09
Zoetis USD 603M 118M 2025-12